TY - JOUR
T1 - Evaluation of alveolar nerve function after surgical lengthening of the mandible by a bilateral sagittal split osteotomy or distraction osteogenesis
AU - Baas, E.M.
AU - de Lange, J.
AU - Horsthuis, R.B.G.
PY - 2010
Y1 - 2010
N2 - This study compares the effects of bilateral sagittal split osteotomy (BSSO) and distraction osteogenesis (DO) for lengthening the mandible regarding loss of function of the inferior alveolar nerve (IAN). In a retrospective cohort study design, the function of the IAN was tested with a Weinstein monofilament 3.22, 1 year after the surgical procedure in 65 patients (35 BSSO; 30 DO). This was defined as the upper limit for normal function. Of 130 IAN studied (70 BSSO, 54%; 60 DO, 46%), nerve function was disturbed in 23 (18%). In this group, 14 cases (61%) had undergone BSSO and 9 (39%) DO. One-hundred and seven nerves had no neurosensory IAN changes; of these BSSO had been performed in 56 cases (52%) and DO in 51 cases (48%). After eliminating confounding factors, there was no significant difference in the occurrence of neurosensory changes between the treatment options (DO versus BSSO, odds ratio: 1.254 with 95% CI: 0.366-4.300). In conclusion, there was no difference in IAN function between patients treated with BSSO or DO for lengthening the mandible.
AB - This study compares the effects of bilateral sagittal split osteotomy (BSSO) and distraction osteogenesis (DO) for lengthening the mandible regarding loss of function of the inferior alveolar nerve (IAN). In a retrospective cohort study design, the function of the IAN was tested with a Weinstein monofilament 3.22, 1 year after the surgical procedure in 65 patients (35 BSSO; 30 DO). This was defined as the upper limit for normal function. Of 130 IAN studied (70 BSSO, 54%; 60 DO, 46%), nerve function was disturbed in 23 (18%). In this group, 14 cases (61%) had undergone BSSO and 9 (39%) DO. One-hundred and seven nerves had no neurosensory IAN changes; of these BSSO had been performed in 56 cases (52%) and DO in 51 cases (48%). After eliminating confounding factors, there was no significant difference in the occurrence of neurosensory changes between the treatment options (DO versus BSSO, odds ratio: 1.254 with 95% CI: 0.366-4.300). In conclusion, there was no difference in IAN function between patients treated with BSSO or DO for lengthening the mandible.
U2 - https://doi.org/10.1016/j.ijom.2010.03.003
DO - https://doi.org/10.1016/j.ijom.2010.03.003
M3 - Article
C2 - 20430586
SN - 0901-5027
VL - 39
SP - 529
EP - 533
JO - International Journal of Oral and Maxillofacial Surgery
JF - International Journal of Oral and Maxillofacial Surgery
IS - 6
ER -
